[{"NetIncomeLoss_2_Q2_USD":-49099000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":399404000.0,"Liabilities_0_Q2_USD":91574000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-4000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"DepreciationAndAmortization_2_Q2_USD":508000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":13091000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":7139000.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":-4000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":967000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-20000.0,"OtherAssetsNoncurrent_0_Q2_USD":31000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":93595000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":35000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":7693000.0,"AssetsCurrent_0_Q2_USD":436846000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":5499999.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":1577000.0,"IncomeTaxesPaidNet_2_Q2_USD":90000.0,"CommonStockSharesIssued_0_Q2_shares":36277511.0,"Assets_0_Q2_USD":439483000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":1000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-4000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":63000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1376000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-27819000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-49098000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":43165000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":24552000.0,"EarningsPerShareBasic_2_Q2_USD":-1.41,"EarningsPerShareBasic_1_Q2_USD":-0.77,"AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_0_Q2_USD":7693000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":34863056.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":36179085.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-2467000.0,"LettersOfCreditOutstandingAmount_0_Q2_USD":275000.0,"ProceedsFromStockPlans_2_Q2_USD":613000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":43000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":28000.0,"AccountsReceivableNetCurrent_0_Q2_USD":1314000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":-4477000.0,"CommonStockValue_0_Q2_USD":4000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":242060000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q2_USD":5308000.0,"CostsAndExpenses_2_Q2_USD":56256000.0,"CostsAndExpenses_1_Q2_USD":31691000.0,"RestrictedCash_0_Q2_USD":275000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":106000000.0,"ShareBasedCompensation_2_Q2_USD":9750000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"AccruedRentNoncurrent_0_Q2_USD":0.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":7231000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-191611000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":297357000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-6000000.0,"CommonStockSharesOutstanding_0_Q2_shares":36277511.0,"EarningsPerShareDiluted_2_Q2_USD":-1.41,"EarningsPerShareDiluted_1_Q2_USD":-0.77,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":12200000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-49099000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-27815000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-38298000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":34863056.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":36179085.0,"LiabilitiesCurrent_0_Q2_USD":34912000.0,"AccountsPayableCurrent_0_Q2_USD":5254000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":399679000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3914000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":4234000.0,"AdditionalPaidInCapital_0_Q2_USD":539536000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":41000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2331000.0,"NetIncomeLoss_1_Q2_USD":-27815000.0,"AccruedRentCurrent_0_Q2_USD":166000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-35000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-205000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":56662000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_2_Q2_USD":1000.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_1_Q2_USD":-4000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":57000.0,"CommonStockSharesAuthorized_0_Q2_shares":400000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":7114000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":3848000.0,"OperatingIncomeLoss_2_Q2_USD":-49142000.0,"OperatingIncomeLoss_1_Q2_USD":-27843000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":32214000.0,"OtherNonoperatingExpense_2_Q2_USD":20000.0,"OtherNonoperatingExpense_1_Q2_USD":7000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":229982000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":21799000.0,"PreferredStockValue_0_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":439483000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":3626000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":9750000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":5308000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":54800000.0,"ProfitLoss_2_Q2_USD":-49099000.0,"StockholdersEquity_0_Q2_USD":347909000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":205000.0,"ConversionOfStockAmountConverted1_2_Q2_USD":0.0,"Ticker":"MORF","CIK":"1679363","name":"MORPHIC HOLDING, INC.","OfficialName":"Morphic Holding Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"1330068663.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210804"}]